Robert M. Califf

Professor of Medicine
Donald F. Fortin, M.D. Professor of Cardiology, in the School of Medicine
Member of the Duke Clinical Research Institute
Campus mail 100 Trent Drive, Suite401, Davison Building, Durham, NC 27710
Phone (919) 668-9222
Email address robert.califf@duke.edu

Robert Califf, MD MACC, is the Donald F. Fortin, MD, Professor of Cardiology. He is also Professor of Medicine in the Division of Cardiology and remains a practicing cardiologist. Dr. Califf was the Commissioner of Food and Drugs in 2016-2017 and  Deputy Commissioner for Medical Products and Tobacco from February 2015 until his appointment as Commissioner in February 2016. Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

Dr. Califf is a Member of the National Academy of Medicine (formerly known as the Institute of Medicine (IOM)) in 2016, one of the highest honors in the fields of health and medicine. Dr. Califf has served on numerous IOM committees, and he has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging.

He has led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke's Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center and co-PI of the Patient Centered Outcomes Research Institute Network.

Associated Faculty Labs

Publications

Mark, DB, Hodgson, P, Anuels, J, and Califf, RM. "Transitions at the american heart journal." American Heart Journal 169, no. 4 (April 2015): 445-null.

PMID
25819848
Full Text

Fordyce, CB, Roe, MT, Ahmad, T, Libby, P, Borer, JS, Hiatt, WR, Bristow, MR, Packer, M, Wasserman, SM, Braunstein, N, Pitt, B, DeMets, DL, Cooper-Arnold, K, Armstrong, PW, Berkowitz, SD, Scott, R, Prats, J, Galis, ZS, Stockbridge, N, Peterson, ED, and Califf, RM. "Cardiovascular drug development: is it dead or just hibernating?." Journal of the American College of Cardiology 65, no. 15 (April 2015): 1567-1582. (Review)

PMID
25881939
Full Text

DeVore, AD, Hasselblad, V, Mentz, RJ, O'Connor, CM, Armstrong, PW, McMurray, JJ, Ezekowitz, JA, Tang, WHW, Starling, RC, Voors, AA, Califf, RM, and Hernandez, AF. "Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF." March 2015.

PMID
25619549
Full Text

Katz, M, Califf, RM, Sun, J-L, McMurray, JJV, Thomas, L, and Lopes, RD. "Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial." The American Journal of Medicine 128, no. 3 (March 2015): 297-302.

PMID
25447626
Full Text

Lam, CSP, McEntegart, M, Claggett, B, Liu, J, Skali, H, Lewis, E, Køber, L, Rouleau, J, Velazquez, E, Califf, R, McMurray, JJ, Pfeffer, M, and Solomon, S. "Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)." European Journal of Heart Failure 17, no. 3 (March 2015): 301-312.

PMID
25655011
Full Text

Spratt, SE, Batch, BC, Davis, LP, Dunham, AA, Easterling, M, Feinglos, MN, Granger, BB, Harris, G, Lyn, MJ, Maxson, PJ, Shah, BR, Strauss, B, Thomas, T, Califf, RM, and Miranda, ML. "Methods and initial findings from the Durham Diabetes Coalition: Integrating geospatial health technology and community interventions to reduce death and disability." Journal of Clinical & Translational Endocrinology 2, no. 1 (March 2015): 26-36.

PMID
29159106
Full Text

Bloomfield, GS, Wang, TY, Boulware, LE, Califf, RM, Hernandez, AF, Velazquez, EJ, Peterson, ED, and Li, JS. "Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseases." Global Heart 10, no. 1 (March 2015): 31-38. (Review)

PMID
25754564
Full Text

Anderson, ML, Chiswell, K, Peterson, ED, Tasneem, A, Topping, J, and Califf, RM. "Compliance with results reporting at ClinicalTrials.gov." The New England Journal of Medicine 372, no. 11 (March 2015): 1031-1039.

PMID
25760355
Full Text

Halim, SA, Neely, ML, Pieper, KS, Shah, SH, Kraus, WE, Hauser, ER, Califf, RM, Granger, CB, and Newby, LK. "Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular events." Circulation. Cardiovascular Genetics 8, no. 1 (February 2015): 168-177.

PMID
25422398
Full Text

Califf, RM. "LCZ696: too good to be true?." European Heart Journal 36, no. 7 (February 2015): 410-412.

PMID
25549727
Full Text

Pages